Back to mobile site

Watson Pharma (WPI) Offers Guidance for FY11 EPS, Sales, EBITDA

January 21, 2011 7:57 AM EST Send to a Friend
Watson Pharma (NYSE: WPI) sees FY11 adj-cash EPS of $3.85-$4.15 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login